Metraipolis › archive › dc_55dd288b754a
HIV-1 infections with multiple founders associate with the development of neutralization breadth — Europe PMC PMID:35303045
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35303045
- DOI
- 10.1371/journal.ppat.1010369
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-26T19:59:48.044Z
- SHA-256 of the archived text
3378dc374ff8ccc80e043bf41fef10286b653828059154977737224468c26f05- Stable URL of this page
https://metraipolis.com/documento/dc_55dd288b754a
How to cite
HIV-1 infections with multiple founders associate with the development of neutralization breadth — Europe PMC PMID:35303045 — Europe PMC (en), https://europepmc.org/article/MED/35303045 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_55dd288b754a (Metraipolis archive dc_55dd288b754a, sha256 3378dc374ff8ccc80e043bf41fef10286b653828059154977737224468c26f05)
BibTeX
@misc{dc55dd288b754a,
title = {HIV-1 infections with multiple founders associate with the development of neutralization breadth — Europe PMC PMID:35303045},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35303045},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_55dd288b754a; sha256 3378dc374ff8ccc80e043bf41fef10286b653828059154977737224468c26f05},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35303045. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Eliciting broadly neutralizing antibodies (bnAbs) is a cornerstone of HIV-1 vaccine strategies. Comparing HIV-1 envelope (env) sequences from the first weeks of infection to the breadth of antibody responses observed several years after infection can help define viral features critical to vaccine design. We investigated the relationship between HIV-1 env genetics and the development of neutralization breadth in 70 individuals enrolled in a prospective acute HIV-1 cohort. Half of the individuals who developed bnAbs were infected with multiple HIV-1 founder variants, whereas all individuals with limited neutralization breadth had been infected with single HIV-1 founders. Accordingly, at HIV-1 diagnosis, env diversity was significantly higher in participants who later developed bnAbs compared to those with limited breadth (p = 0.012). This association between founder multiplicity and the subsequent development of neutralization breadth was also observed in 56 placebo recipients in the RV144 vaccine efficacy trial. In addition, we found no evidence that neutralization breath was heritable when analyzing env sequences from the 126 participants. These results demonstrate that the presence of slightly different HIV-1 variants in acute infection could promote the induction of bnAbs, suggesting a novel vaccine strategy, whereby an initial immunization with a cocktail of minimally distant antigens would be able to initiate bnAb development towards breadth. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2022 (prima pubblicazione 2022-03-18). Identificativi: PMID 35303045 · PMCID PMC8967031 · DOI 10.1371/journal.ppat.1010369. Descrittori MeSH principali: HIV-1. Pagina: https://europepmc.org/article/MED/35303045 — https://doi.org/10.1371/journal.ppat.1010369. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-26T19:47:19.448Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.